Early Sepsis Indicator Biomarker
Help identify adult patients in the emergency department who have sepsis or are at increased risk of developing sepsis with the exclusive Early Sepsis Indicator. The only FDA-cleared hematology biomarker for sepsis, Early Sepsis Indicator measures monocyte distribution width (MDW) to support prompt clinical decision making for this often-deadly condition. This sepsis parameter is available as part of a routine CBC with differential, enabling automatic reporting without added workload burden.
Peer-Reviewed Clinical Study MDW Aids Early Sepsis Detection in the Emergency Department Beyond SIRS and qSOFA
New analysis from the pivotal study shows that patients with abnormal values of MDW at presentation have increased odds of sepsis.Read study
Webinar The Science Behind Early Sepsis Indicator: Why Do Monocytes Matter?
Learn how monocytes contribute to the development of sepsis and discover the scientific evidence behind a new monocyte biomarker.View on demand
REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license.